NCCN Guidelines for Patients® | Ovarian Cancer - page 61

Part 7: Recurrence treatment
NCCN Guidelines for Patients
: Ovarian cancer
Version 1.2013
Par t 1
Par t 2
Par t 3
Par t 4
Par t 5
Par t 6
Par t 7
Par t 8
Par t 9
Par t 10
that kill all cells that grow
rapidly, including normal
cells and cancer cells
Chemicals in
the body that activate cells
or organs
cancer doesn’t respond
(doesn’t improve or go
away) to a chemotherapy
drug made with platinum
The cancer responds
(improves or goes away) to
a chemotherapy drug made
with platinum
Single agent:
The use of
one drug
Recurrence treatments include chemotherapy, targeted therapy, and hormone
therapy. Which chemotherapy drug you will receive depends on whether the
cancer responded to the initial treatment with platinum-based chemotherapy—
carboplatin or cisplatin. (See page 41 for details about chemotherapy.) Targeted
therapy is designed to specifically attack and kill cancer cells. Targeted therapy
drugs may be less likely to harm normal cells than chemotherapy. Bevacizumab
(sold as Avastin
) is a targeted therapy drug used for ovarian cancer. It works
by stopping the growth of new blood vessels that feed cancer cells. Hormone
therapy drugs treat ovarian cancer by stopping the body from making certain
hormones or stopping the effect of hormones in the body.
1...,51,52,53,54,55,56,57,58,59,60 62,63,64,65,66,67,68,69,70,71,...100
Powered by FlippingBook